EORTC protocol 22055 - 08053

Phase III study comparing post-operative conformal radiotherapy to no post-operative radiotherapy in patients with completely resected non-small cell lung cancer and mediastinal N2 involvement - LUNG-ART
Trial StatusRecruiting
DatesDate of activation: 23-Apr-13
Data management at EORTCMailbox
Phase3
Randomized trialYes
TypePeriadjuvant
Targeted Sample sizeEORTC Groups: 200 - All Groups: 700
Number of steps1
Drug
Study StaffCecile Le Pechoux (Study Coordinator) - Institut Gustave Roussy, Villejuif
Laurence Collette (Statistician) - EORTC Headquarters, Brussels
Isabelle Meulders (Data Manager) - EORTC Headquarters, Brussels
Emad Shash (Coordinating Physician) - EORTC Headquarters, Brussels
Julie Hermans (Project Manager) - EORTC Headquarters, Brussels, julie.hermans( at )eortc.be, +32 27741673
Type of cancerLung
Participating GroupsInstitut Gustave Roussy(Coordinating Group)
EORTC Lung Cancer Group
EORTC Radiation Oncology Group
Centers authorized by EORTC
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00410683
EudraCT
Protocol documents in PDF
(requires password)
Study documentation
Back to Protocol section